Evidence map›Paper›PMID 41030929›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Multiplex serology reveals age-specific immunodynamics of endemic respiratory pathogens in the wake of the COVID-19 pandemic.

Samantha J Bents, Emily T Martin, Terry Steven-Ayers, Claire Andrews, Amanda Adler, Amanda Perofsky, Elizabeth M Krantz, Rachel Blazevic, Louise Kimball, Robin Prentice and 13 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Samantha J BentsEmmett Interdisciplinary Program in Environment and Resources, Stanford University, Stanford, CA, United States.ORCID 0009-0003-9298-945X
Emily T MartinDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, United States.
Terry Steven-AyersVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.ORCID 0000-0002-7546-8439
Claire AndrewsVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Amanda AdlerDivision of Pediatric Infectious Diseases, Seattle Children's Hospital, Seattle, WA, United States.ORCID 0009-0008-9732-3565
Amanda PerofskyFogarty International Center, National Institutes of Health, Bethesda, MD, United States.ORCID 0000-0001-7341-9193
Elizabeth M KrantzVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Rachel BlazevicVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Louise KimballVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Robin PrenticeVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Chelsea HansenFogarty International Center, National Institutes of Health, Bethesda, MD, United States.
Lea StaritaBrotman Baty Institute, University of Washington, Seattle, WA, United States.
Peter HanBrotman Baty Institute, University of Washington, Seattle, WA, United States.
Janet A EnglundDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Washington, Seattle, WA, United States.
Nicole WolterCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Anne von GottbergCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Lorens MaakeCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Jocelyn MoyesCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Cheryl CohenCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Michael BoeckhVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
James A HayPandemic Sciences Institute, Nuffield Department of Medicine,, University of Oxford, Oxford, United Kingdom.
Alpana WaghmareVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Cécile ViboudFogarty International Center, National Institutes of Health, Bethesda, MD, United States.

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00015 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HENSLEY, SCOTT · 2021 to 2025
$50.7M
NIAID NIH HHS 75N93021C00015Wellcome Trust
6 · The paper itself

Abstract

The rebound of endemic respiratory viruses following the COVID-19 pandemic was marked by atypical transmission dynamics, with children experiencing increased disease burden and out-of-season epidemics as restrictions relaxed. Here we used serology from a newly developed quantitative multiplex assay to assess the post-pandemic immunity debt, a drop in immunity due to a lack of endemic virus circulation during COVID-19. We assessed age-specific antibody dynamics in Seattle, Washington, US, across a broad range of respiratory viruses, including influenza, respiratory syncytial virus, seasonal coronaviruses, and SARS-CoV-2. We found that respiratory virus immunodynamics differed between individuals <5 years of age and older individuals, with young children experiencing both larger boosts and quicker waning of antibodies across pathogens. We confirmed that these patterns are upheld in a non-pandemic setting by analyzing influenza serological data from South Africa. We incorporated our serological insights into an influenza transmission model calibrated to epidemiological data from Seattle and show that consideration of age-specific immunodynamics may be important to anticipate the effects of pandemic perturbations.

Identifiers

PMID41030929
PMCPMC12478342

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.